GLAUKOS Corp chief development officer Tomas Navratil reported selling 1,615 common shares on September 25, 2026, across four transactions: 167 shares at a weighted-average $151.70 per share, 136 at $152.71, 229 at $154.24 and 1,083 at $154.88. The sales were made under a Rule 10b5-1 trading plan adopted June 12, 2026; each reported price reflects multiple trades.
GLAUKOS Corp (GKOS) officer Tomas Navratil reported a proposed sale of 1,615 common shares, with an aggregate market value of $249,157.98 and an approximate sale date of September 25, 2026. Fidelity Brokerage Services LLC is listed as broker, with NYSE as the exchange. Restricted stock vesting on March 22, 2025, is listed as the shares’ source. Earlier reported sales were 716 shares on July 1, 2026, 13,744 shares on August 28, 2026, and 1,457 shares on September 16, 2026.
GLAUKOS Corp (GKOS) reported that its Chief Development Officer, Tomas Navratil, sold a total of 1,457 shares of common stock on September 16, 2026 in a series of open‑market transactions under a Rule 10b5-1 trading plan adopted on June 12, 2026.
The weighted‑average sale prices for the trades ranged from about $163.20 to $172.00 per share, and the officer’s holdings include 38,817 restricted stock units that have not yet vested or been delivered.
GLAUKOS Corp (GKOS) is the issuer for a Rule 144 notice filed on behalf of officer Tomas Navratil covering planned sales of 1,457 shares of common stock. The shares relate to restricted stock vesting events dated March 22, 2025 (709 shares) and March 24, 2025 (748 shares), listed as compensation.
The notice also lists prior open-market sales by Tomas Navratil over the last three months, including transactions on June 16, 2026, July 1, 2026, and August 28, 2026, with share counts and dollar amounts disclosed.
GLAUKOS Corp (GKOS) reported that chief development officer Tomas Navratil sold a total of 13,744 shares of common stock on August 28, 2026, in three open-market transactions. The sales covered 7,643 shares at a weighted average price of $180.25 (with individual trades between $179.69 and $180.69), 6,091 shares at a weighted average price of $181.19 (with trades between $180.71 and $181.61), and 10 shares at $182.50. The prices reported are weighted averages, and detailed trade breakdowns are available upon request. Following these transactions, Navratil’s equity holdings include 38,817 restricted stock units that have not yet vested or been delivered.
GLAUKOS Corp (GKOS) insider Tomas Navratil, identified as an officer, filed a notice of proposed sale of 13,744 shares of common stock under Rule 144 through Fidelity Brokerage Services LLC. The shares have an aggregate market value of $2,483,097.96. Common shares outstanding were 58,983,937 as of August 28, 2026.
GLAUKOS Corp (GKOS) director Gilbert H. Kliman exercised stock options for 2,500 shares of common stock on 2026-08-19 at an exercise price of $25.77 per share. The resulting 2,500 common shares were then sold the same day at $190.00 per share. After the exercise, Kliman continued to hold stock options for 12,500 shares, and his equity awards also include 2,501 restricted stock units that are unvested or deferred.
GLAUKOS Corp (GKOS) is the issuer for a planned resale of its common stock under Rule 144 by shareholder Gilbert H. Kliman. The notice covers the potential sale of 2,500 shares of Glaukos common stock through Fidelity Brokerage Services LLC on or after 08/19/2026 on the NYSE.
The shares to be sold are tied to a stock option exercise for cash, with an aggregate market value listed as $475,000.00. Fidelity signed the notice as attorney-in-fact for Kliman.
GLAUKOS Corp president and COO Joseph E. Gilliam reported multiple option exercises and related stock sales for GKOS on 2026-08-11. He exercised options covering 60,000 shares of Common Stock and acquired an equal number of shares, then sold 60,000 Common shares in two open-market transactions at weighted average prices of $178.89 and $180.49 per share. He also continues to hold 41,983 restricted stock units and 225 stock units from the Employee Stock Purchase Plan, which remain unvested or undelivered.
Glaukos Corp senior vice president and chief financial officer Alex R. Thurman reported an options exercise and same-day sale of common stock. On August 7, 2026, he exercised stock options for 20,000 shares of common stock at an exercise price of $33.81 per share and acquired those shares, then sold 20,000 shares of common stock at a weighted average price of $180.13 per share in a sale in open market or private transactions. The option exercises and sale were effected pursuant to a Rule 10b5-1 trading plan adopted on December 15, 2025. Following these transactions, his reported holdings include 5,230 restricted stock units that have not yet vested or been delivered and 225 stock units purchased through the Employee Stock Purchase Plan.